Private Private
Nanosynex
Rapid Diagnostic Test for Bacterial Infections
ABOUT

Nanosynex is a diagnostic test that checks bacterial resistance to antibiotics in record time using a phenotypic approach involving microfluidic techniques and fluorescent-based analysis. The solution will be sold to clinical laboratories in the form of disposable cards and a fluorescent reading device.

The test offers same-day results to help doctors quickly determine the most appropriate antibiotic treatment for their patients, enabling shorter recovery times, preventing the spread of resistant bacteria into the environment, and saving significant healthcare costs by limiting prolonged hospitalization.

Nanosynex is developed in the lab of Prof. Levenberg, Dean of the Technion Biomedical Engineering Faculty, and has a partnership with Biosynex, a French company in the rapid diagnostic industry with a distribution network in 60 countries.

Read More
Read Less
TAGS
VERTICAL MARKETS
TEAM
IN THE NEWS
RELATED COMPANIES
Add to Collection
Request intro
COMPANY PROFILE
GEOGRAPHICAL MARKETS
PRODUCTS
ISRAEL
Technion DRIVE Accelerator, Haifa, Israel
NANOSYNEX'S TIMELINE
NOW
Expand All